ONCAREX

In 2007, Celonic has in-licensed ONCAREX, an L-aminooxidase. ONCAREX is a protein providing a broad anti-tumor activity. Originally, the protein was isolated from the slug Aplysia punctata. Its potential in cancer therapy has already been proven in-vitro and in-vivo in established animal models. ONCAREX is to be developed in the therapy of head and neck cancer.